Iridian Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-10,000
Closed -$788K 81
2016
Q2
$788K Sell
10,000
-5,000
-33% -$376K 0.01% 63
2016
Q1
$1.08M Sell
15,000
-10,000
-40% -$757K 0.01% 54
2015
Q4
$2.11M Sell
25,000
-20,000
-44% -$1.66M 0.02% 49
2015
Q3
$3.77M Hold
45,000
0.03% 48
2015
Q2
$3.76M Buy
+45,000
New +$3.43M 0.03% 50

Other funds holding LLY

Iridian Asset Management's LLY Position: Q3 2016 in Review

Iridian Asset Management sold out of Eli Lilly (LLY) in Q3 2016, closing a stake of 10,000 shares — an estimated $788K sold.

Iridian Asset Management first reported a position in LLY in Q2 2015 and held it in 5 quarters. The position peaked at $3.77M in Q3 2015. 1,176 funds tracked by Wall St. Rank hold LLY as of Q3 2016.

  • Iridian Asset Management reported no remaining Eli Lilly position as of Q3 2016 after selling out during the quarter.
  • Iridian Asset Management sold 10,000 Eli Lilly shares in Q3 2016, an estimated $788K.
  • Iridian Asset Management first reported a position in Eli Lilly in Q2 2015 and held it in 5 quarters.
  • Iridian Asset Management's Eli Lilly position peaked at $3.77M in Q3 2015.
  • 1,176 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.

Based on Iridian Asset Management's 13F filing for Q3 2016, filed 9 Nov 2016.